Accept Lazard M&A or A&M RX?
Hey all, recently got extended offers to both LAZ M&A and Alvarez and Marsal's RX (both in T1 cities), and am debating which offer to pick. Decided to create an acc. and browse on here before posting, but saw a bunch of posts talking about Lazard going downhill, so just wanted to be sure. Does that still apply, or is it an outdated POV?
I've also talked to a bunch of ppl (on the buyside and in IB), and responses have been mixed, so am looking for a tiebreak.
If anyone's got any insights would love to hear them.
What do you want to do in the long run?
Two main exits I see myself in 1) C-suite 2) Buyside (ambivalent between trad or distressed PE). So, I guess a follow up question would be what outcome is more likely: Taking the Laz offer and breaking into a good PE firm or taking the A&M offer and getting into a C-suite (CFO / CRO / COO / CEO) role at a good firm?
Others have said it but I agree that you should definitely take the Lazard offer. The opportunity gives you the most range in terms of exit opportunities, and its a better brand name regardless. If you wanted to go to distressed credit/PE, you should have RX advisory expeirence at a PJT/HL etc
If you are looking to do investment banking, Lazard is the much better option. Lazard is a world renowned investment bank with an incredible M&A franchise. They also do very well in the restructuring space (though, note your post says M&A group). I wouldn't get too caught up in day-to-day posts, Lazard remains a very highly respected place to work and incredible experience out of college with great buyside positioning. A&M is a consulting firm with a strong restructuring franchise, but fundamentally it is not an investment bank. If you want that type of restructuring consulting experience, I wouldn't steer someone away from A&M, but if you are looking for the more traditional finance route, go with Lazard.
Yeah that makes sense, but I feel like I'm more focused on the exits from both. Do you have any insight on what each would position me better for?
If you're looking to do a buyside role, Lazard M&A is going to carry the most weight.
From the consulting perspective are you open to traveling 80% of the year? Not sure what travel is like in IBD but this could sway you.
Traveling economy**
Veritatis ea omnis atque incidunt veniam. Possimus dolores rerum vel aperiam unde voluptatibus impedit. Assumenda sint labore delectus et repudiandae maxime odit.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...